Avenzo
10 known investors
Avenzo Therapeutics is a clinical-stage biopharmaceutical company developing therapeutic treatments. The company focuses on oncology and cell therapy programs.
Biotech
Founders & leadership
AC
Athena CountouriotisCo-Founder, Chief Executive Officer
Investors · 10
Competitors · 2
by search overlapBioworld11 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Agenus11 shared keywords
Companies competing with Avenzo for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · Jul 2026Frequently asked questions
- What does Avenzo do?
- Avenzo Therapeutics is a clinical-stage biopharmaceutical company developing therapeutic treatments. The company focuses on oncology and cell therapy programs.
- Who founded Avenzo?
- Avenzo was founded by Athena Countouriotis.
- Who are Avenzo's investors?
- Avenzo's investors include Delos Capital, Foresite Capital, INCE Capital, Longwood Fund, New Enterprise Associates (NEA), OrbiMed, Quan Capital, Sofinnova Ventures and 2 more.